AKT1 and lung cancer: Irrespective of the mechanism, the frequent enhancement of PI3K/Akt/mTOR activation suggests in lung cancer suggests an important role for the pathway in carcinogenesis, thus providing strong impetus for the development of targeted agents directed at inhibiting the PI3K/Akt/mTOR pathway.